Nwam LLC Takes $195,000 Position in Grail, Inc. (NASDAQ:GRAL)

Nwam LLC purchased a new position in Grail, Inc. (NASDAQ:GRAL) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 10,908 shares of the company’s stock, valued at approximately $195,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Douglas Lane & Associates LLC bought a new stake in Grail during the 4th quarter valued at approximately $3,034,000. A. D. Beadell Investment Counsel Inc. bought a new position in shares of Grail during the fourth quarter worth $430,000. FNY Investment Advisers LLC purchased a new position in Grail during the fourth quarter valued at $26,000. 180 Wealth Advisors LLC bought a new stake in Grail in the 4th quarter valued at $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management bought a new stake in Grail in the 4th quarter valued at $387,000.

Grail Stock Performance

Shares of GRAL opened at $38.56 on Monday. The company’s fifty day moving average is $28.90 and its 200 day moving average is $20.16. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99.

Grail (NASDAQ:GRAL) last posted its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping analysts’ consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. As a group, sell-side analysts anticipate that Grail, Inc. will post -15.15 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Wolfe Research assumed coverage on Grail in a research report on Friday, November 15th. They set a “peer perform” rating for the company. Morgan Stanley began coverage on Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price target for the company.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.